2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2412
  



  

  
Submitter : 
  

  
Mrs. Peggy Schlitz
  

  
Date & Time: 
  

  
12/01/2006 08:12:54
  



  

  
Organization : 
  

  
Mrs. Peggy Schlitz
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Im writing in regard to docket number 2006D0383.  I urge the FDA to recommend that pharmaceutical companies use cell lines which have originated from ethical and non-controversial sources for the development of vaccines, instead of from aborted children.